logo-loader
viewHealthcare Locums PLC

Healthcare Locums tumbles after US hedge funds take legal action

courthouse_350_4f4df900df5ce.jpg

Healthcare Locums (LON:HLO) lost a fifth of its value in early trade after revealing that an American hedge fund has filed proceedings against the recruitment firm.

The proceedings have been filed by Permian Master Fund, Permian Investments Partners, Arundel Capital, Arundel Long Fund, Arundel Hedge Fund, Privet Capital and Flinn Investments.

The summons and complaint allege that Healthcare Locums, which provides recruitment services to healthcare and social care companies, and three of its former directors misrepresented the company’s profitability and accounting practices in 2010.

“The summons and complaint have not as yet been served...however, the company is taking legal advice and will update shareholders as and when appropriate,” Healthcare Locums said in the statement.

Back in November, the company changed its adviser, appointing Investec as its nominated adviser and broker, while Deloitte was named its new auditor, replacing BDO.

The change came a year after shares in the company were suspended due to accounting irregulatiries.

“These are important new appointments that will aid the Company's progress as it continues along its path of recovery,” said chairman of Healthcare Locums Peter Sullivan.

Shares in the group slid 21 percent to 2.7 pence in early trade, giving it a market cap of £848 million.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: THC Global Group granted GMP Licence for Southport cannabis...

THC Global Group Limited (ASX:THC) chief executive officer Ken Charteris updates Proactive on being granted a licence to manufacture therapeutic goods for the company’s Southport Facility, known as a GMP Licence, by the Australian Therapeutic Goods Administration (TGA). This milestone...

18 hours, 31 minutes ago

2 min read